Analyzing Revolutions Medical (OTCMKTS:RMCP) and InspireMD (NYSE:NSPR)

InspireMD (NYSE:NSPR) and Revolutions Medical (OTCMKTS:RMCP) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Insider & Institutional Ownership

44.8% of InspireMD shares are owned by institutional investors. 34.1% of InspireMD shares are owned by insiders. Comparatively, 10.5% of Revolutions Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares InspireMD and Revolutions Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$7.78 million	10.84	-$19.92 million	($0.84)	-2.37
Revolutions Medical	N/A	N/A	N/A	N/A	N/A

Revolutions Medical has lower revenue, but higher earnings than InspireMD.

Profitability

This table compares InspireMD and Revolutions Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Revolutions Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for InspireMD and Revolutions Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0	0	1	0	3.00
Revolutions Medical	0	0	0	0	0.00

InspireMD presently has a consensus price target of $4.00, indicating a potential upside of 101.01%. Given InspireMD’s stronger consensus rating and higher probable upside, research analysts plainly believe InspireMD is more favorable than Revolutions Medical.

Risk and Volatility

InspireMD has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Revolutions Medical has a beta of -0.43, suggesting that its stock price is 143% less volatile than the S&P 500.

Summary

InspireMD beats Revolutions Medical on 7 of the 10 factors compared between the two stocks.

About InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.